Sarasota Memorial Health Care System (SMH) reported that 75% of lung cancers diagnosed through an innovative early detection program at SMH's Brian D. Jellison Cancer Institute in 2025 were found at ...

Summary of Phase 1 Zoldonrasib Data at AACR 2026 ( Abstract # CT021 ) ...

Many of us think we know the key causes and symptoms of lung cancer. However, there are still some misconceptions about the ...

An investigational targeted therapy doubled survival compared with standard chemotherapy for pretreated individuals with ...

The incidence and mortality rate of esophageal cancer in China fell by around 4.5 percent annually, according to the figures ...

Exceptional measures of efficacy observed in THIO-101 Phase 2 trial to date include disease control, response rates, and survival data well above ...

The profile of lung cancer patients is shifting, in part due to factors such as radon, air pollution and genetics. Screening ...

Lung cancer is the deadliest cancer—but early screening can save lives. A survivor’s story and expert insight show why ...

Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

The American Lung Association in New York is inviting the New York City community to unite as one mighty force for lung ...

Revolution Medicine has wowed investors and analysts by announcing dazzling data from its Phase III RASolute 302 trial ...